ストックスクリーナーアプリを入手
1,064.74
0.02%
-0.26
プレマーケット:
1068.00
3.26
+0.31%
Lilly Eli Co (LLY) 最新ニュース
Trump declares perfect health after Walter Reed physical; Eli Lilly spends $4B on three vaccine developers; obesity leveling off in wealthy nations, still rising elsewhere – Morning Medical Update - Medical Economics
Eli Lilly acquires Novo Holdings-backed Limmatech for USD 780m - medwatch.com
Micron Hits $1 Trillion, Overtakes JPMorgan, Walmart And Eli LillyMicron Technology (NASDAQ:MU) - Benzinga
Key facts: Lilly buys 3 vax for up to $4B; PCSK9↓88% LDL‑C↓62%; BofA up GLP‑1 - TradingView
Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree - The Daily Upside
GC Biopharma Sells U.S. Affiliate Curevo to Eli Lilly for 459.9 Billion Won - Businesskorea
Eli Lilly Set to Acquire Curevo, LimmaTech Biologics, and Vaccine Co. for $4 Billion - scanx.trade
Lilly buys three vaccine firms to target dementia and infection preventionCHOSUNBIZ - Chosunbiz
Micron Just Became America's 10th-Most-Valuable Company. Wall Street Says It Could Pass Tesla and Meta Next. - The Motley Fool
How The Eli Lilly (LLY) Narrative Is Evolving With GLP-1 Hopes And Obesity Market Doubts - Yahoo Finance
Eli Lilly Buys 3 Vaccine Companies for $3.8B - Powder & Bulk Solids
GC Green Cross Sells U.S. Affiliate Curevo to Eli Lilly - 아시아경제
Former Metro councilman and pastor accused in 'fraud scheme' to steal $200 million from drug company - News Channel 5 Nashville
Lilly spending nearly $4B to acquire three vaccine developers - Inside INdiana Business
Lilly Is Looking for Its Next Act Beyond the Weight-Loss Boom - Barron's
Lilly to acquire three vaccine developers for up to $3.83 billion By Investing.com - Investing.com Canada
Eli Lilly and Company to acquire 3 vaccine development companies for nearly $4 billion - WTHR
Eli Lilly Expands Vaccine Push With Deals Worth Up To $3.8B - Law360
Eli Lilly acquires three vaccine companies for infectious disease portfolio - Managed Healthcare Executive
Lilly goes on $20 billion buying spree as company seeks next act - The Daily Gazette
What's Going On With Eli Lilly Stock Tuesday?Eli Lilly (NYSE:LLY) - Benzinga
Lilly to buy three vaccine developers for up to $3.8 billion - MSN
Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion - marketscreener.com
Lilly Goes on $20 Billion Buying Spree as Company Seeks Next Act - Yahoo Finance
Lilly Gets Back Into the Vaccine Business With New Deals - marketscreener.com
LLY: Eli Lilly Acquires Three Vaccine Developers for $3.8 Billio - GuruFocus
Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms - Proactive financial news
Lilly buys three vaccine makers; PCSK9 base editor shows promise - BioWorld News
Early data for heart drug affirm Lilly’s billion-dollar bet on Verve - BioPharma Dive
Lilly dives into vaccine research with 3 biotech buyouts - BioPharma Dive
Eli Lilly spending $3.8 billion to buy vaccine makers - Axios
Healthcare Takeovers Tick Pass $140 Billion After Latest Lilly Spree - Bloomberg.com
Lilly goes on $21B buying spree to build drug pipeline - dailyjournal.net
Lilly to buy three vaccine developers for nearly US$4 billion in infectious disease push - CTV News
Eli Lilly and Co. splashes out $3.8 billion to acquire three companies, aiming to get a head start in the next round of the global vaccine race - 富途牛牛
Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - upi.com
Analyst recommendations: Eli Lilly, AutoZone, BP plc, Ferrari, Samsung Electronics… - marketscreener.com
Positive Clinical Data for Eli Lilly's Gene Editing Therapy VERVE-102 - GuruFocus
Eli Lilly Bets Nearly $4 Billion on Vaccines: Is the Weight-Loss Drug Giant’s Next Growth Curve Here? - TradingKey
Lilly Expands Into Vaccines With Three Infectious Disease Acquisitions Worth Up to $3.8 Billion - citybiz
Lilly to Acquire Vaccine Company in $1.55 Billion Bet on Epstein-Barr Vaccine Development - citybiz
Lilly to Acquire Curevo in Deal Focused on Next-Generation Shingles Vaccine - citybiz
Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology
Eli Lilly and Co (LLY) Stock Price, Trades & News - GuruFocus
Lilly Agrees to Buy Trio of Vaccine Developers - WSJ
Here’s What the Street is Saying About Eli Lilly and Company (LLY) - Insider Monkey
Eli Lilly (LLY) Acquires Three Vaccine Firms for Nearly $4 Billi - GuruFocus
Eli Lilly's VERVE-102 Shows Promising Results in Early Trial - GuruFocus
Eli Lilly (LLY) Expands Vaccine Portfolio with $4B in Acquisitio - GuruFocus
Eli Lilly (LLY) Expands Infectious Disease R&D Through New Acqui - GuruFocus
Lilly (LLY) to Acquire LimmaTech Biologics for Up to $780 Millio - GuruFocus
Eli Lilly to acquire Curevo, LimmaTech Biologics and Vaccine Company in multibillion dollar bet on infectious - CNBC TV18
LLY Acquires Vaccine Company Focused on Innovative Nanoparticle Technology - GuruFocus
LLY Expands Vaccine Portfolio with Curevo Acquisition - GuruFocus
Lilly to buy three vaccine developers for up to US$3.8 bil - The Edge Malaysia
Eli Lilly Doubles Down On Vaccines Portfolio; Makes Three Key Acquisitions For Nearly $4 Billion - NDTV Profit
Is LLY Overvalued? DCF Says Worth $762 - GuruFocus
Lilly acquiring three vaccine developers for nearly $4-billion - The Globe and Mail
Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company - investor.lilly.com
Eli Lilly (LLY) Expands Portfolio with Infectious Disease Acquis - GuruFocus
Lilly to acquire three vaccine developers for up to $3.83 billion - Investing.com
BofA raises Eli Lilly stock price target on GLP-1 growth outlook - Investing.com
Lilly to acquire three vaccine developers for nearly $4 billion - Reuters
Lilly to acquire three vaccine developers in deals worth up to $4B - Seeking Alpha
1.78%
0.09%
大文字化:
|
ボリューム (24 時間):